Showing results (401-410 of 440) with videos related to
Sort By:
Pageof 44
Archives of Internal Medicine|March 1, 1989
Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration?D A Johnson, W E Drane, J Curran, et al.The American Journal of Gastroenterology|February 24, 2001
Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safetyD A Johnson, S B Benjamin, N B Vakil, et al.Cytometry|February 15, 1997
Measurement of CD69 induction in the assessment of immune function in asymptomatic HIV-infected individualsS P Perfetto, T E Hickey, P J Blair, et al.Cancer Research|June 1, 1991
In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexesJ J Starling, R S Maciak, K L Law, et al.Journal of Medicinal Chemistry|January 21, 1994
Total synthesis and biological properties of novel antineoplastic (chloromethyl)furanoindolines: an asymmetric hydroboration mediated synthesis of the alkylation subunitsF Mohamadi, M M Spees, G S Staten, et al.Lancet (London, England)|April 9, 1983
Outbreak of central-nervous-system toxoplasmosis in western Europe and North AmericaB J Luft, F Conley, J S Remington, et al.Journal of Clinical Immunology|May 1, 1997
Impaired induction of the apoptosis-protective protein Bcl-xL in activated PBMC from asymptomatic HIV-infected individualsP J Blair, L H Boise, S P Perfetto, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 3, 1998
Size and duration of zidovudine benefit in 1003 HIV-infected patients: U.S. Army, Navy, and Air Force natural history data. Military Medical Consortium for Applied Retroviral ResearchL I Gardner, S H Harrison, C W Hendrix, et al.Alimentary Pharmacology & Therapeutics|September 30, 2000
Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study InvestigatorsP J Kahrilas, G W Falk, D A Johnson, et al.Journal of the National Medical Association|May 1, 1994
Management of penetrating colon injuriesP J Bostick, J S Heard, J T Islas, et al.Pageof 44